• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

One-year clinical outcome of patients with nonvalvular atrial fibrillation: Insights from KERALA-AF registry
CONCLUSIONS: Despite high risk profile of patients in this registry, use of OAC was suboptimal, whereas antiplatelets were used in nearly half of patients. A relatively high rate of annual mortality and hospitalization was observed in patients with NVAF in Kerala AF Registry.PMID:33714410 | PMC:PMC7961260 | DOI:10.1016/j.ihj.2020.11.152
Source: Indian Heart J - March 14, 2021 Category: Cardiology Authors: C G Bahuleyan Narayanan Namboodiri A Jabir Gregory Y H Lip George Koshy A Babu M Shifas Kartik Viswanathan S Geevar Zachariah K Venugopal Eapen Punnose K U Natarajan G K Mini Johny Joseph Ashokan Nambiar C P B Jayagopal P P Mohanan Raju George Govindan Un Source Type: research

Data on vildagliptin and vildagliptin plus metformin combination in type-2 diabetes mellitus management
Bioinformation. 2021 Mar 31;17(3):413-423. doi: 10.6026/97320630017413. eCollection 2021.ABSTRACTIt is of interest to evaluate the clinical effectiveness and safety of vildagliptin as monotherapy and combination therapy of vildagliptin and metformin for the management of type 2 diabetes mellitus (T2DM) patients in Indian settings. The study included patients with T2DM (aged >18 years) receiving vildagliptin monotherapy and vildagliptin in combination with metformin therapy of various strengths. Data related to demographics, risk factors, medical history, glycated hemoglobin (HbA1c) levels, and medical therapies were ret...
Source: Bioinformation - June 7, 2021 Category: Bioinformatics Authors: Sambit Das A K Gupta Biplab Bandyopadhyaya B Harish Darla Vivek Arya Mahesh Abhyankar Santosh Revankar Source Type: research

Vaccination in Older Adults: An Underutilized Opportunity to Promote Healthy Aging in India
AbstractOver the last 50 years, the Indian population aged 50 years and above (older adults) has quadrupled and is expected to comprise 404 million people in 2036, representing 27% of the country ’s projected population. Consequently, the contribution of chronic disease to older adults’ total burden of diseases in India is likely to escalate. Disease burden is notably amplified by immunosenescence, a deterioration of the immune system that develops with age, leading to increasing suscept ibility to infectious diseases and other comorbidities. Older adults with infectious diseases have a higher incidence and likelihood ...
Source: Drugs and Aging - June 14, 2021 Category: Geriatrics Source Type: research

Data on vildagliptin and vildagliptin plus metformin combination in type-2 diabetes mellitus management
Bioinformation. 2021 Mar 31;17(3):413-423. doi: 10.6026/97320630017413. eCollection 2021.ABSTRACTIt is of interest to evaluate the clinical effectiveness and safety of vildagliptin as monotherapy and combination therapy of vildagliptin and metformin for the management of type 2 diabetes mellitus (T2DM) patients in Indian settings. The study included patients with T2DM (aged >18 years) receiving vildagliptin monotherapy and vildagliptin in combination with metformin therapy of various strengths. Data related to demographics, risk factors, medical history, glycated hemoglobin (HbA1c) levels, and medical therapies were ret...
Source: Bioinformation - June 7, 2021 Category: Bioinformatics Authors: Sambit Das A K Gupta Biplab Bandyopadhyaya B Harish Darla Vivek Arya Mahesh Abhyankar Santosh Revankar Source Type: research

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13